This session will differentiate the Military Health Systen (MHS) from the Veterans Health Administration (VHA), discuss historical and current policies regarding genetics relevant to each system, and review counseling considerations for patients served by the MHS and VHA. A case example is included to demonstrate different counseling considerations for patients in the MHS vs. VHA.

Presented by:
NSGC Military SIG
1. Lydia Hellwig, PhD, ScM, CGC
2. Emily Bonham, MS, CGC

Learning Objectives:

1. Recognize the Military Health System (MHS) and compare/contrast with the Veterans Health Administration (VA).
2. Discuss the historical and current policies regarding genetics and the military and VA.
3. Differentiate some military- and Veteran-specific considerations of genetic and genomic information.

Program Overview

Please Note: You are not required to complete all modules of the JoGC CEU Program to earn CEUs and you may earn partial credit for the program. You may choose to complete some or all modules. You will only be awarded CEUs for those modules which you pass and complete in full, including the module quiz and evaluation. Please review the CEU credit section below for additional information on available contact hours and certificates.

Continuing Education Unit (CEU) Credits

The Journal of Genetic Counseling CEU Program is approved for 12.0 Contact Hours or 1.2 Category 1 CEU. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification. Individuals must be certified at the time of participation in the activity in order to count towards recertification. 

Register by November 30, 2026 to participate. Program materials must be completed by December 11, 2026 to earn CEUs. CEU certificates will be issued via the NSGC CEU Portal no later than December 18, 2026. Early certificates are not available. 

Access to the Journal of Genetic Counseling (JoGC) is required to participate in the 2026 Journal of Genetic Counseling CEU Program. NSGC members receive complimentary access to the Journal of Genetic Counseling. Please note that non-members are required to purchase access to the Journal of Genetic Counseling separately if they do not already have access to this publication to participate in this program.

Member Price: $220
Non-member Price: $250

This session will explore emerging prenatal therapies for lysosomal storage disorders, including in utero enzyme replacement and gene therapy. Attendees will learn about the PEARL Trial, the first clinical study of prenatal enzyme replacement therapy, along with early safety and outcome data. The session will also examine future applications of fetal gene therapy and the evolving role of genetic counselors in early diagnosis, patient counseling, care coordination, and access to prenatal precision medicine.

Presented By:

NSGC Metabolism & Lysosomal Storage Diseases SIG
1. Billie Lianoglou, ScM, CGC

Learning Objectives:

1. Describe the clinical rationale and emerging evidence supporting prenatal intervention for severe monogenic disorders, with a focus on in utero enzyme replacement therapy for lysosomal storage diseases.
2. Review the design, implementation, and interim outcomes of the PEARL Trial, including patient selection, procedural considerations, and early safety and efficacy findings.
3. Recognize benefits and limits related to prenatal administration of AAV9 gene insertion for GM1 gangliosidosis including data from the pediatric experience and rationale for moving the intervention to the prenatal period.
4. Discuss the role of the UCSF Center for Genome Surgery in integrating genomic diagnosis, therapeutic development, and clinical translation to expand access to precision therapies for patients with rare genetic diseases.
5. Highlight emerging opportunities and challenges for genetic counselors as prenatal genomic therapies move from rese

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Fetal Therapy for Monogenic Disorders - PEARL Trial: In Utero Enzyme Replacement Therapy for Lysosomal Storage Diseaseses. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Content expires December 31, 2027.

Member Price: $35
Non-member Price: $50

This all-inclusive package offers access to the full set of 24 webinars from NSGC’s 2026 Webinar Series, complete with CEUs. Please note that webinars will be added to this package as they are released.

To purchase the 2026 NSGC Webinar Series Full Package, click the blue "Register Now" button next to the package title. Do not register for the individual components included in the package.

Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to 2.4 CEUs or 24 Category 1 contact hours for the 2026 NSGC Webinar Series Full Package. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Content expires December 31, 2027.

Member Price: $400
Non-member Price: $475

As next-generation sequencing (NGS) becomes the standard of care, a laboratory's competitive advantage is no longer defined by the test itself, but by how effectively it leverages data, automation, and innovation. Laboratories that embrace AI, invest in scalable data infrastructure, and integrate intelligent workflows are better positioned to increase efficiency, expand testing capacity, and contribute to learning health systems.

Join us to explore how AI can be applied responsibly throughout the case review process. Discover which tasks can be automated, where human expertise delivers the greatest value, and how to achieve the right balance between efficiency and scientific oversight.

Presented by:

NSGC Genomic Technologies SIG
1. Talia Silver, MHSc

Learning Objectives:

1. Explain the technical layer of genomics lab operations.
2. Explain different forms of AI, where and how they can be used, and what guardrails can enable safe adoption in a lab setting.
3. Explain how automation, and utilization of software stand to improve lab operations.
4. Explain how structured data storage enables reanalysis and research and what it can enable for healthcare systems.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Software and AI: How Responsible Use Enables Analysis and Variant Curation at Scale. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Content expires December 31, 2027.

Member Price: $35
Non-member Price: $50

This session pulls back the curtain on modern genetic testing laboratories, mapping out the lifecycle of a sample from initial accessioning to complex variant classification and reporting. Panelists will demystify the operational, regulatory, and business constraints that shape lab policies, explaining the root causes behind turnaround times and reporting limitations. By addressing the perspective gap between clinic and laboratory, attendees will learn practical strategies to troubleshoot common delays and collaborate effectively with lab genetic counselors for better patient care.

Presented by:

NSGC Lab/Industry SIG
1. Matt Tschirgi, MS, CGC
2. Elizabeth Kramer Dugan, MGC, CGC
3. Elysia Pagano, MGC, CGC

Learning Objectives:

1. Evaluate the operational, business, and cross-functional drivers behind genetic testing laboratory decisions, business metrics, and turnaround times.
2. Trace the journey of a sample through accessioning, triage, automation, and reporting.
3. Identify factors that impact testing capacity and workflow limitations.
4. Analyze the root causes of discrepancy between clinical expectations and lab capabilities, including requisition requirements, variant classification constraints, and reporting policies.
5. Apply practical communication strategies and best practices—such as providing detailed phenotype data and engaging effectively with lab genetic counselors—to streamline case management and optimize patient outcomes.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Things I Wish I Knew in Clinic: The Realities of Lab Operations and Industry. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Content expires December 31, 2027.

Member Price: $35
Non-member Price: $50

Join us for an engaging, case-based webinar that brings the realities of genetic counseling into focus through complex, real-world clinical scenarios. In this interactive session, expert genetic counselors will present challenging cases, including a prenatal whole exome sequencing workup that led to variant reclassification, cascade testing across an extended family, and unexpected management implications for the pregnant patient; and a family undergoing repeated diagnostic and counseling shifts as new genetic evidence challenged established disease expectations. Together, these cases highlight evolving genetic knowledge, complex result interpretation, nuanced risk assessment, and the counseling strategies needed to support patients and families facing uncertainty.

Presented by:

1. Nour Chanouha, MS, CGC
2. Hannah S. Anderson, MS, CGC

Learning Objectives:

1. Evaluate complex genetic results disclosure plans based on multiple clinical and psychosocial factors.
2. Describe how family history, fetal phenotype, and evolving variant interpretation can guide the interpretation of prenatal genetic testing and inform recurrence risk and family management.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Case Based Webinar - Part IV. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Content expires December 31, 2027.

Member Price: $35
Non-member Price: $50

Prenatal skeletal dysplasias are among the most challenging conditions to diagnose and counsel prenatally due to variable phenotypic expression, evolving genotype-phenotype correlations, and limitations of prenatal imaging and molecular testing. While advances in genomic technologies have improved diagnostic capabilities, predicting clinical outcomes, including survival, severity, and long-term prognosis, often remains uncertain.

This webinar will review current approaches to the prenatal evaluation of suspected skeletal dysplasias and explore the challenges of prognostication in the context of uncertain or evolving information. Through clinical cases, participants will examine practical counseling strategies for communicating uncertainty, supporting informed decision-making, and providing patient-centered care for families navigating complex prenatal diagnoses of skeletal dysplasia.

Presented by: 

NSGC Skeletal Dysplasia SIG
1. Shannon Persick, MS, CGC

Learning Objectives:

1. Review the most common prenatal presentations of skeletal dysplasias.
2. Describe the major factors that contribute to prognostic uncertainty in prenatal skeletal dysplasia evaluation, including limitations of ultrasound examination, molecular testing, and genotype phenotype correlations.
3. Illustrate the spectrum of clinical outcomes associated with prenatal skeletal dysplasia diagnoses through real-life case examples.
4. Recognize common psychosocial challenges experienced by families navigating a new diagnosis of skeletal dysplasia in both the prenatal and neonatal periods.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Prenatal Skeletal Dysplasias: Navigating Prognostic Uncertainty and Counseling Challenges. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Content expires December 31, 2027.

Member Price: $35
Non-member Price: $50

Advancements in genomic knowledge and next generation sequencing technologies have resulted in expanded carrier screening creating more equitable opportunities for individuals to learn about their reproductive risks for various genetic conditions including inherited eye and hearing conditions.  For many of the ocular and auditory conditions included in carrier screening panels there are wide spectrums of phenotypic features including age of onset and severity.  In this webinar, we discuss some common carrier screening findings for ocular and auditory conditions and offer strategies for providing a nuanced approach to genetic counseling about ocular and auditory conditions.

Presented by: 

NSGC Ophthalmology and Hearing Loss SIG
1. Shay Guetz-Lindahl, MS, CGC
2. Emily Place, MS, LCGC

Learning Objectives:

1. Define the spectrum of presentation of ocular genetic conditions found on carrier screening.
2. Define the spectrum of presentation of hearing loss genetic conditions on carrier screening.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Spectrum of Senses: Insights and Caveats for navigating ocular and auditory genetics in prenatal and preconception counseling. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Content expires December 31, 2027.

Member Price: $35
Non-member Price: $50

This webinar examines how genetic counselors are implementing pharmacogenomics (PGx) testing and counseling across healthcare settings. Over 95% of the population carries clinically significant pharmacogene variants, yet implementation lags behind other genetic testing due to limited workforce training, provider literacy gaps, and high clinical decision support costs. The presenters showcased three primary PGx service delivery models: academic medicine programs (Brigham & Women's Hospital telemedicine clinic and M Health Fairview's Go4PGx Initiative), private practice collaborations between genetic counselors and pharmacists, and laboratory-based models such as Color Health's integration with cancer clinics and research partnerships. Future challenges include managing increasingly complex sequencing-based and polygenic score PGx results while capitalizing on opportunities from long-read genomics and rapid sequencing technologies. Training programs and continuing education must expand to meet growing clinical integration of PGx and establish counselor competency as a hiring differentiator.

Presented by: 

NSGC Precision Medicine SIG
1. Hannah Llorin, MS, CGC
2. Elizabeth Fieg, MS, CGC
3. Hetanshi Naik, PhD, MS, CGC
4. Jen Eichmeyer, MS, CGC
5. Jeri Nichols, MS, PharmD, CGC, CSP
6. Carla McGruder, MS, CGC
7. Rissa Hall, MS, CGC

Learning Objectives:

1. Explain the clinical relevance and utility of pharmacogenomics (PGx)
2. Identify barriers to PGx implementation in genetic counseling practice and recognize emerging opportunities to advance the field
3. Compare genetic counselor roles and responsibilities across academic, private practice, and laboratory-based PGx models

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, From Niche to Necessary: Genetic Counselor-Led Pharmacogenomics Across the Care Continuum. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Content expires December 31, 2027.

Member Price: $35
Nonmember Price: $50